More evidence intratumoral DHT synthesis drives castration-resistant prostate cancer

Asian Journal of Andrology

Volumn 16, Issue 1, 2014, Pages 99-100

  Wilson, Elizabeth M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17 HYDROXYPREGNENOLONE; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; 3BETA HYDROXYSTEROID DEHYDROGENASE 1; ANDROGEN RECEPTOR; ANDROSTANOLONE; MESSENGER RNA; PRASTERONE; STEROID 5ALPHA REDUCTASE; TESTOSTERONE; UNCLASSIFIED DRUG;

ANDROGEN DEPRIVATION THERAPY; ANDROGEN METABOLISM; ANDROGEN SYNTHESIS; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CASTRATION RESISTANT PROSTATE CANCER; CONGENITAL ADRENAL HYPERPLASIA; GAIN OF FUNCTION MUTATION; GENE FUNCTION; GENETIC SELECTION; HETEROZYGOSITY LOSS; HUMAN; ISOMERIZATION; MALE; SOMATIC MUTATION; TESTOSTERONE SYNTHESIS; VIRILIZATION;

3-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; DIHYDROTESTOSTERONE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 84891940452     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.4103/1008-682X.122200     Document Type: Article

References (15)

1. Geller J, Albert J, Loza D, Geller S, Stoeltzing W, et al. DHT concentrations in human prostate cancer tissue. J Clin Endocrinol Metab 1978; 46: 440-4.
2. Mohler JL, Gregory CW, Ford OH, Kim D, Weaver CM, et al. The androgen axis in recurrent prostate cancer. Clin Cancer Res 2004; 10: 440-8.
3. Mostaghel EA, Page ST, Lin DW, Fazli L, Coleman IM, et al. Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: Therapeutic implications for castration-resistant prostate cancer. Cancer Res 2007; 67: 5033-41.
4. Montgomery RB, Mostaghel EA, Vessella R, Hess DL, Kalhorn TF, et al. Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth. Cancer Res 2008; 68: 4447-54.
5. Locke JA, Guns ES, Lubik AA, Adomat HH, Hendy SC, et al. Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer. Cancer Res 2008; 68: 6407-15.
6. Chang KH, Li R, Kuri B, Lotan Y, Roehrborn CG, et al. A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer. Cell 2013; 154: 1074-84.
7. Evaul K, Li R, Papari-Zareei M, Auchus RJ, SharifiN. 3beta-hydroxysteroid dehydrogenase is a possible pharmacological target in the treatment of castration-resistant prostate cancer. Endocrinology 2010; 151: 3514-20.
8. Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 2011; 32: 81-151.
9. Mohler JL, Titus MA, Bai S, Kennerley BJ, Lih FB, et al. Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancer. Cancer Res 2011; 71: 1486-96.
10. Tan JA, Sharief Y, Hamil KG, Gregory CW, Zang DY, et al. Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen dependent human prostate cancer xenograft CWR22 and LNCaP cells. Mol Endocrinol 1997; 11: 450-9.
11. He B, Gampe RT, Hnat AT, Faggart JL, Minges JT, et al. Probing the functional link between androgen receptor coactivator and ligand binding sites in prostate cancer and androgen insensitivity. J Biol Chem 2006; 281: 6648-63.
12. Auchus RJ. The backdoor pathway to dihydrotestosterone. Trends Endocrinol Metab 2004; 15: 432-8.
13. de Bono JS, Logothetis CJ, Molina A, Fizazi K, North S, et al. Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med 2011; 364: 1995-2005.
14. Li R, Evaul K, Sharma KK, Chang KH, Yoshimoto J, et al. Abiraterone inhibits 3β-hydroxysteroid dehydrogenase: A rationale for increasing drug exposure in castration-resistant prostate cancer. Clin Cancer Res 2012; 18: 3571-9.
15. Hofland J, van Weerden WM, Dits N F, Steenbergen J, van Leenders GJ, et al. Evidence of limited contributions for intratumoral steroidogenesis in prostate cancer. Cancer Res 2010; 70: 1256-64.